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Expression quantitative trait loci (eQTL) studies are used to interpret the function of 
disease-associated genetic risk factors. To date, most eQTL analyses have been 
conducted in bulk tissues, such as whole blood and tissue biopsies, which are likely 
to mask the cell type context of the eQTL regulatory effects. Although this context 
can be investigated by generating transcriptional profiles from purified cell 
subpopulations, the current methods are labor-intensive and expensive. Here we 
introduce a new method, ​Decon2,​ a statistical framework for estimating cell 
proportions using expression profiles from bulk blood samples (Decon-cell) and 
consecutive deconvolution of cell type eQTLs (Decon-eQTL). The estimated cell 
proportions from Decon-cell agree with experimental measurements across cohorts 
(R ≥ 0.77). Using Decon-cell we can predict the proportions of 34 circulating cell 
types for 3,194 samples from a population-based cohort. Next we identified ​16,362  
whole blood eQTLs and assign them to a cell type with Decon-eQTL using the 
predicted cell proportions from Decon-cell. Deconvoluted eQTLs show excellent 
allelic directional concordance with those of eQTL(≥ 96%) and chromatin mark QTL 
(≥87%) studies that used either purified cell subpopulations or single-cell RNA-seq. 
Our new method provides a way to assign cell type effects to eQTLs from bulk blood, 
which is useful in pinpointing the most relevant cell type for a certain complex 
disease. Decon2 is available as an R package and Java application 
(https://github.com/molgenis/systemsgenetics/tree/master/Decon2), and as a web 
tool ( ​www.molgenis.org/deconvolution ​). 
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For many of the genetic risk factors that have been associated to immune diseases by 
genome-wide association studies (GWAS), the molecular mechanism leading to disease 
remains unknown ​1​. Most of these genetic risk variants are located in the non-coding regions 
of the genome, implying that they play a role in gene regulation ​2,3​. Expression quantitative 
trait locus (eQTL) analysis provides a way to characterize the regulatory effect of these risk 
factors in humans, and many eQTL studies have now been carried out using bulk tissues, for 
example, whole blood ​4,5​. However, bulk tissues comprise many different cell types, and gene 
regulation is known to vary across cell types​6–8​. In recent years, efforts to describe eQTL 
effects in purified cell subpopulations have been carried out in specific cell types​9​. 
Unfortunately, the length and cost of the study protocols have limited these studies to small 
sample sizes and only a few cell types. Nevertheless, being able to pinpoint the particular 
cell type (CT) in which a risk factor exerts an eQTL effect could help us to understand its role 
in disease. 
  
Statistical approaches to detect CT effects using tissue expression profiles have mainly been 
developed to evaluate gene by environment interaction (GxE) terms, for example, being able 
to detect CT eQTLs for myeloid and lymphoid lineages using only whole blood gene 
expression and by evaluating the interaction between genotype and cell proportions for 
neutrophils and lymphocytes in whole blood ​10​. A second study linked eQTL genes to proxy 
genes through correlation; these proxy genes were then associated to intrinsic or extrinsic 
factors, such as cell proportions or inflammation markers​11​. However, these efforts focused 
on exploiting only one GxE term, or on indirectly linking the CT proportions to given eQTL 
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 instead of directly ascertaining the interaction between all the main cell proportions 
comprising the bulk tissue and genotype. Unfortunately, quantifying cell proportions, in 
particular for rare subpopulations (total abundance of ≤ 3% in circulating white blood cells), is 
expensive and time-consuming. Hence, quantifying immune cell proportions in large 
functional genomics cohorts is not common practice. 
  
Here we present and validate Decon2, a computational and statistical framework that can: 
(1) predict the proportions of known circulating immune cell subpopulations (Decon-cell), and 
(2) use these predicted proportions along with whole blood gene expression and genotype 
information to assign bulk eQTL effects into CT eQTLs (Decon-eQTL). Our two-step 
framework provides an improvement over previously published methods. As unlike earlier 
methods​12​, Decon-cell does not rely on any prior information of transcriptome profiles from 
purified cell subpopulations, as it only requires the proportions of the cells comprising the 
bulk tissue, in this case whole blood, and identifies signature genes which correlate with cell 
proportions in a bulk tissue. ​Secondly, Decon-eQTL is the first approach in which all major 
cell proportions (the major cell types for which the sum of proportions per sample to 
approximately 100%) of bulk blood tissue are incorporated into an eQTL model 
simultaneously. This can then be systematically tested for any significant interaction 
between each CT and genotype, while at the same time the effect of  the other CTs are 
modelled. 
 
We generated the Decon-cell predictive models using data from the  500FG cohort​13​, where 
quantification of immune cell types was carried out using FACS​14​ and RNA-Seq based bulk 
whole blood transcriptome profiling were available for 89 samples​15​. By using a 
cross-validation approach we were able to accurately predict 34 out of 73 cell subtypes 
using solely whole blood gene expression. For validation, we applied  Decon-cell to three 
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 independent cohorts (Lifelines Deep ​16​, n = 627, Leiden Longevity cohort​17​, n= 660 and the 
Rotterdam Study​18​, n= 773) with both blood RNA-seq and measured cell proportion data 
available (neutrophils, lymphocytes and CD14+ monocytes and granulocytes). Additionally, 
we benchmarked Decon-cell prediction performance against two other existing methods that 
quantify immune cell composition using gene expression profiles from whole blood. After 
showing that we can accurately predict circulating immune cell proportions, we applied 
Decon-cell to estimate cell proportions in 3,194 individuals from the BIOS cohort​16,19–21​, in 
which both whole blood RNA-seq and genotypes were available. The BIOS cohort is a 
valuable resource for functional genomics studies where extensive characterization of the 
genetic component on gene expression ​11​ and epigenetics ​22​ have been performed. We 
integrated whole blood expression, genotype information and predicted cell proportion with 
Decon-eQTL, to deconvolute 16,362 significant whole blood cis-eQTLs top effects into CT 
eQTLs. These deconvoluted eQTL results were comprehensively validated using 
transcriptome profiles from purified cell subpopulations​23​, eQTLs and chromatin mark QTLs 
from purified cell types​9​, and eQTLs from single-cell experiments​24​. We also systematically 
compared the performance of Decon-eQTL against previously published methods​10​-11​ that 





Decon-cell accurately predicts the proportions of known immune cell types 
In order to assign the CT in which an overall eQTL effect from a bulk tissue sample (e.g. 
whole blood), we need three types of information: genotype data, tissue expression data, 
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 and cell type proportions (​Fig. 1​). Here, we propose a computational method for predicting 
the cell proportions of known immune cell types using gene signatures in whole blood 
expression data by employing a machine-learning approach. Decon-cell employs the 
regularized regression method elastic net​25​ to define sets of signature genes for each cell 
type. In other words, these signatures were selected as having the best prediction power for 
individual cell proportions.  
  
There are 89 samples in 500FG cohort with both whole blood RNA-seq and quantification of 
73 immune cell subpopulations by FACS available. This data was used to build the 
prediction models for estimating cell subpopulations by Decon-cell. First we determined 
which of the 73 cell subpopulations could be reliably predicted by Decon-cell. A within-cohort 
cross-validation strategy was employed by randomly dividing 89 samples (​Fig. 1​) into 
training and test sets (70% and 30% of the samples, respectively ). After generating a model 
using each training set, we applied the prediction models of each cell type to the samples in 
the test sets. We compared the predicted and measured cell proportion for each cell type 
using Spearman correlation coefficients to evaluate the  prediction performance. We 
repeated this process 100 times and then used the mean correlation coefficient in all 100 
iterations to evaluate the prediction performance. We were able to predict 34 out of 73 cell 
subpopulations using whole blood gene expression data at a threshold of mean absolute R ≥ 
0.5 across all 100 iterations (​Fig. 2A, Supplementary Fig.1 , ​Supplementary Table 1). The 
number of signature genes selected in the models for predicting cell proportions varied 
across the cell types, ranging from 2 to 217 signature genes (Supplementary Fig. 2A, 
Supplementary Table 1); and it was independent of the average abundance of these cell 
types in whole blood (R = 0.02, Spearman correlation coefficient, Supplementary Fig.2A). In 
particular, cell types that are abundant in whole blood (granulocytes-neutrophils, CD4+ 
T-cells, CD14+ monocytes) were predicted with high confidence (correlation between 
5 
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/548669doi: bioRxiv preprint 
 predicted and measured values, R ≥ 0.73). Remarkably, we were also able to predict a 
number of less abundant cell subpopulations, including NK cells, CD8+ T-cells, non-NK 
T-cells (CD3- CD56-) including CD4+ central memory and CD4+ effector memory T-cells, 
and regulatory T-cells (Supplementary Fig. 2A) as determined by FACS. Cell types with a 
low prediction performance (R < 0.5) are those that have few signature genes whose 
expression levels correlate sufficiently (i.e. absolute R < 0.3) with the actual cell proportions 
in whole blood (Supplementary Fig. 2B-C). For each of the 34 predictable cell types, we 
used Decon-cell to build models for predicting their cell counts using all 89 samples from the 
500FG cohort. These models were applied to 3,194 samples in an independent cohort, to 
predict cell proportions of circulating immune cell types for the subsequent deconvolution of 
eQTL effect.  
  
In addition to within-cohort validation, we tested our cell proportion models using three 
independent cohorts (LLDeep, n = 627, LLS, n= 660, RS, n =773), for which cell type 
abundances were quantified using a Coulter counter for neutrophils (granulocytes for RS), 
lymphocytes, and CD14+ monocytes (​Fig. 2B, Supplementary Fig. 3A-B​). In LLDeep we 
were able to accurately predict these three cell types with Spearman correlation coefficients 
of R = 0.73, R = 0.89, and R = 0.73, respectively.  For LLS and RS the prediction 
performance was also accurate for neutrophils and lymphocytes, but less accurate for 
monocytes (R= 0.76 for neutrophils, R= 0.50 for CD14+ monocytes and R= 0.84 for 
lymphocyte proportions in LLS, R= 0.74 for granulocytes, R= 0.28 for CD14+ monocytes and 
R= 0.83 for lymphocytes in RS).  
 
Next, in order to benchmark Decon-cell we have compared its prediction performance 
against two other existing tools that quantify the abundance of known immune cell types 
using bulk whole blood expression profiles: CIBERSORT​26​ and xCell ​12​. We obtained the 
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 predicted proportions by CIBERSORT and enrichment scores of circulating immune cells by 
xCell for the samples in three different cohorts: LLDeep, LLS and RS (Supplementary Fig. 
4A-B). For each cell type,  Decon-cell outperforms CIBERSORT and xCell (Supplementary 
Fig. 3B). The scatterplots of predicted vs measured values  (Supplementary Fig. 3 A, and 
Supplementary Fig. 4 A-B) further demonstrate that the better performance of Decon-cell is 
not due to cell proportion outliers. 
 
Finally, we evaluated whether the signature genes showed CT expression in their relevant 
purified cell types, using the BLUEPRINT​23​ RNA-seq data from the purified cell 
subpopulations. We focused on cell types with more than three samples measured, these 
included neutrophils, CD14+ monocytes, CD4+ T-cells and B-cells. The signature genes 
showed overall higher expression in their relevant cell subpopulations compared to other cell 
subpopulations. Interestingly, the signature genes were also able to cluster the samples of 
the relevant CT using unsupervised hierarchical clustering (Supplementary Fig. 5A-D). 
Together, our results demonstrated that the gene signatures identified by Decon-cell were 
predictive for the proportions of circulating immune cell subpopulations using only whole 
blood gene expression data. 
  
To facilitate the cell proportion prediction of new samples using whole blood RNA-seq, we 
have made the Decon-cell prediction models and gene signatures available in an R package 
(Decon-cell) and as a web tool (www.molgenis.org/deconvolution). These two 
implementations allow the user to pre-process their RNA-seq expression counts and 
estimate cell proportions using the pre-established models for 34 cell types in whole blood. 
Decon-cell R package also allows the user to input bulk expression profiles and cell 
proportions to generate predictive models for new tissues. 
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 Decon-eQTL assigns bulk eQTLs to cell types eQTL effects 
As we know, eQTL analysis using whole blood bulk expression data fails to distinguish 
between a general eQTL that is present in all cells and an effect that is mainly found in a 
particular cell subpopulation, or subset of one, significantly more than the others present in 
the tissue. We therefore propose a new approach to assign the overall bulk eQTL into CT 
effects, called Decon-eQTL (see ​Online Methods ​). By using the cell proportions in whole 
blood, is possible to formally test if the genetic effect is dependent on cell proportions. More 
explicitly, we include both the genotype and all CT proportions of interest in a linear model 
and systematically test if there is a significant interaction effect between the genotype and 
each of the predicted cell proportions in the variation of gene expression in whole blood. At 
the same time we control the effect of the remaining CTs. In this way, whole blood 
expression data, alongside genotypes and (predicted) cell proportions can be integrated to 
assign a CT effect from a bulk eQTL(Fig. 1). 
  
We applied Decon-eQTL to 3,198 samples (BIOS cohort) with transcriptome levels 
(RNA-seq), genotype information and cell proportions predicted by Decon-cell. Whole blood 
cis​-eQTL mapping yielded 16,362 whole blood eQTLs (false discovery rate (FDR) ≤ 0.05). 
For each of these whole blood ​cis​-eQTLs, we applied Decon-eQTL with a focus on 6 major 
cell subpopulations: granulocytes, CD14+ monocytes, CD4+ T-cells, CD8+ T-cells, B-cells 
and NK cells. These cell types were selected as the sum of their relative percentages was 
close  to 100% and none of these cell type pairs had an absolute correlation coefficient R ≥ 
0.75. Decon-eQTL computationally assigned 4,139 CT eQTLs from these subpopulations, 
reflecting 3,812 genes and 3,650 SNPs. We observed that 25% of the whole blood eQTLs 
have a significant (FDR ≤ 0.05) CT eQTL effect given Decon-eQTL. The majority (31%) of 
the total CT-eQTL effects detected were found to be associated to granulocyte, possibly 
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 because granulocytes comprise ~70% of circulating white blood cells (​Fig. 3A​). We also 
observed that the majority (74%) of CT eQTLs detected by our method were assigned to a 
single cell type. It should be noted that these eQTL are likely not exclusively present for this 
particular cell type in biology, but that the statistical power was sufficient to detect CT eQTL 
in this particular cell type ​(​Supplementary Fig. 6). We found sharing of eQTLs for between 
cell types only in few cases. An example of such shared eQTLs is on ​NOD2 gene​, where 
Decon-eQTL was able to detect a strong granulocyte-eQTL effect alongside a smaller, 
opposite effect in CD14+ monocytes. This opposite effect has also been previously 
described in eQTL studies on purified CD14+ monocytes and neutrophils​8​. These results 
demonstrate that cell type effects should be taken into account when interpreting eQTLs 
derived from bulk tissues. 
  
Decon-eQTL prioritizes genes to relevant cell types 
To further validate our deconvoluted CT eQTLs, we systematically tested if the expression 
levels of the CT eQTL genes detected in the BIOS cohort were correlated with their relevant 
cell proportions. We calculated the Spearman correlation coefficients between the 
expression of the identified CT eQTL genes and the measured cell proportions using the 
500FG cohort (n = 89). Next, we compared the correlation coefficients obtained with those 
between expression and the remaining cell proportions. For each of the six evaluated cell 
subpopulations in Decon-eQTL, CT eQTL genes had a significantly higher correlation with 
their relevant cell subpopulation than the other cell types (T test, p-value < 0.05) (​Fig. 3B​). 
As such, this result validates the association of the CT-eQTL genes and the cell proportions 
in an independent cohort. 
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 Next, we evaluated whether the significant CT eQTL genes were over-expressed in their 
relevant cell subpopulation compared to eQTL genes that were found to be non-significant 
for the same cell type. For this purpose, we made use of the purified neutrophil, CD14+ 
monocyte, CD4+ T-cell and B-cell RNA-seq data from the BLUEPRINT dataset. We only 
include these cell types as they were the only ones with more than 3 samples measured. For 
each of the four cell types, we observed that the expression of CT eQTL genes detected by 
Decon-eQTL was significantly higher (T-test, p-value ≤ 0.05) compared to the expression of 
non-significant Decon-eQTL genes (​Fig. 4A​). We also observed that the deconvoluted eQTL 
genes from granulocytes showed a relatively wider range of variation than the CT-eQTL 
genes from the other three subpopulations. We hypothesized that this could be explained by 
the fact that granulocytes comprise ~70% of the cell composition in whole blood, thus giving 
us the power to detect eQTL for lowly-expressed genes in granulocytes. This was partly 
supported by the observation that the variation of expression in whole blood for granulocyte 
eQTL genes was significantly greater than those eQTL genes deconvoluted to the other five 
cell subpopulations (F test, p-value ≤ 0.05, Supplementary Fig. 7).  
 
Furthermore, by using a publicly available transcriptome profiles  (​GSE78840 ​27 ​) ​of purified NK 
cells and CD4+ T cells, we assessed if the differentially expressed genes across the two cell 
types were enriched for eGenes of deconvoluted CT eQTLs. We observed that the CD4+ 
differentially expressed genes (Adjusted P-value ≤ 0.05) were significantly enriched for 
CD4+ T cell eQTLs (Fisher exact P = 1.8x10 ​-17​), whereas NK cell differential genes (Adjusted 
P-value ≤ 0.05) were significantly enriched for NK cell eQTLs (Fisher exact P = 2.3x10 ​-18​) as 
shown in ​Fig.4B​. 
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 In summary, we were able to show that the eQTL genes detected by Decon-eQTL have a 
relevant cell-type effect given we have been able to show that transcriptionally active in their 
relevant cell type 
  
CT eQTLs identified by Decon-eQTL in whole blood are replicated in purified 
cell eQTL datasets 
In order to validate the CT eQTLs defined by decon-eQTL, we utilized the eQTLs identified 
from purified neutrophils, CD4+ T-cells and CD14+ monocytes​9​. We first compared the 
absolute effect sizes from purified cells between significantly deconvoluted CT eQTLs, with 
non-significant deconvoluted CT eQTLs for this CT. For all three cell populations, effect 
sizes in our deconvoluted CT eQTLs were significantly higher compared to the effect size of 
eQTLs without a significant CT eQTL (Wilcoxon test, p-value ≤ 0.05, ​Fig. 4C​). Next, we 
assessed the specificity of our deconvoluted CT eQTLs by evaluating CT-eQTL effect sizes 
in non-relevant cell subpopulations. For example, we compared the effect sizes of 
deconvoluted granulocyte eQTLs against those with non-significant deconvoluted 
granulocyte eQTLs using the effect sizes of purified CD4+ T-cell eQTLs. Notably, we 
observed no statistically significant differences using effect sizes from non-relevant cell 
subpopulations (see off-diagonal comparisons in Supplementary Fig. 8), further supporting 
the biological significance of our deconvoluted CT eQTLs. 
To further demonstrate that the cell type eQTLs assigned by Decon-eQTL are biologically 
relevant, we have made use of the K27AC and K4ME1 epigenetic QTLs characterized using 
purified neutrophils, CD4+ T-cells and monocytes CD14+​9​. In a similar fashion as the above 
comparison of effect sizes with purified eQTLs, we compared the absolute effect sizes from 
both K27AC and K4ME1 QTLs from eQTLs for which Decon-eQTL detects a CT effect 
against the rest of whole blood eQTLs. We observed that for corresponding cell types, e.g. 
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 evaluating granulocyte CT eQTLs in K27AC QTLs from purified Neutrophils, the distribution 
of the absolute effect sizes is significantly higher for the chromatin mark QTLs (cmQTLs) 
than those non-significant CT eQTLs, which provide an epigenetic evidence that  our method 
is able to assign correctly the cell type eQTL effects, as shown in the diagonal comparisons 
in both K27AC QTLS (Supplementary Fig.9) and for K4ME1 QTLs (Supplementary Fig.10). 
Notably, we observed that for the non-relevant cell subpopulations only one comparison, i.e. 
granulocytes v.s. CD14+ monocytes, show a statistically significant higher effect sizes for 
K27AC QTLs and K4ME1 QTLs, although the difference in effect sizes is less pronounced 
as the ones observed with corresponding cell types. For the rest of the non-relevant 
comparisons in the off-diagonal of both Supplementary Fig.9 and Supplementary Fig.10, 
there are no statistically significant differences. 
In addition to the comparison of effect sizes, we ascertained the allelic concordance between 
deconvoluted eQTLs and eQTLs from purified cell subtypes​9​. For each available CT 
(neutrophils, CD14+ monocytes, and CD4+ T cells), we evaluated whether the direction of 
the eQTL effect on deconvoluted CT eQTLs was the same as the one observed from purified 
cell subpopulations. Remarkably, the allelic concordance between the deconvoluted eQTLs 
and purified eQTLs was high across cell types: 99% for granulocyte eQTLs (compared to 
neutrophil eQTLs), 96% for CD14+ monocytes eQTLs, and 99% for CD4+ T cells (​Fig. 5A​). 
These rates of allelic concordance are significantly higher for deconvoluted granulocyte and 
CD4+ T-cell eQTLs compared to the those between whole blood eQTLs and eQTLs from 
purified cell subpopulations (​Fig. 5B, ​Neutrophils, Fisher exact p-value = 3.91x10 ​6​, CD4+ T 
cells Fisher exact p-value = 0.005),  whereas the allelic concordance for deconvoluted 
CD14+ monocyte eQTLs is the same as for whole blood eQTLs and purified CD14+ 
monocyte eQTLs (​Fig. 5B ​). We also compared the allelic concordance of deconvoluted 
CT-eQTLs of a certain cell type against the eQTLs of non-relevant purified subpopulations. 
Interestingly, the allelic concordance across non-relevant cell subtypes is consistently lower 
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 (off-diagonal Supplementary Fig.11). The higher allelic concordance across CTs was seen 
between deconvoluted granulocyte eQTLs and CD14+ monocyte eQTLs with a 95% allelic 
concordance, which shows that the direction of effect is often shared between related cell 
types.  
Finally, we evaluated the allelic concordance rates for CT eQTLs assigned by Decon-eQTL 
and K27AC QTLs from purified cell subpopulations, where we observed a consistently high 
allelic concordance rate: 92% for granulocyte eQTLs (in purified Neutrophils), 87% for 
CD14+ monocytes and 92% for CD4+ T cells (boxed diagonal comparisons in 
Supplementary Fig. 12). These concordance rates are significantly higher than the ones 
between the whole blood eQTLs and K27AC QTLs from purified cell subpopulations 
(Supplementary Fig 13) for neutrophils (Fisher exact test p-value = 9.06x10 ​-14​), CD14+ 
monocytes (Fisher exact test p-value = 3.33x10 ​-4​), C4+ T cells (Fisher exact test p-value = 
8.64x10 ​-9​). Remarkably we also notice a consistent decrease on concordance rates when 
assessing the allelic concordance of CT eQTLs in K27AC QTLs of non-relevant cell 
subpopulations (off-diagonal compasons, Supplementary Fig. 12). Together, the results from 
allelic concordance rates between deconvoluted CT eQTLs and eQTLs/K27AC QTLs from 
purified cell subpopulations add a further layer of evidence supporting the biological 
relevance of deconvoluted CT eQTLs. 
 
CT eQTLs identified by Decon-eQTL in whole blood show allelic concordance 
with single-cell RNA-seq eQTLs 
To replicate the deconvoluted CT eQTLs in the cell subtypes that were not available in Chen 
et al ​9​. purified cell eQTLs, we utilized the recent single-cell RNA-seq eQTLs (sc-eQTLs) 
identified in CD14+ monocytes, NK cells, CD4+ T-cells, CD8+ T-cells, and B-cells​24​.​ We 
selected the top SNP per sc-eQTL pair for each of the cell types and compared it to the 
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 direction of the eQTL effect given by Decon-eQTL. Overall we observed an allelic 
concordance of 98% (​Fig. 5C ​and Supplementary Table 3). This allelic concordance is 
higher than the one achieved on comparing the direction of whole blood eQTL effects with 
sc-eQTLs, where we observed an allelic concordance of 89% (Supplementary Fig. 14). 
Although the difference is not statistically significant (Fisher exact p-value = 0.1102), we 
expect that replication can be achieved for more rare cell types when single cell eQTL 
datasets with a larger sample size become available.  
  
Decon-QTL outperforms earlier methods 
 
To our knowledge, our approach is the first to model the effect of multiple components of 
bulk blood RNA-seq to deconvolute cell type effects. Previous studies used an interaction 
effect between genotype and cell proportions of one specific cell type to detect the cell type 
eQTLs effects using whole blood gene expression ​10,11​, or used the correlation of the eQTL 
effect with cell type proxy genes​10,11​.  
 
The Westra ​et al ​ method has often been used to detect cell type eQTL effects using bulk 
expression data and cell proportions​28–31​. In brief, it focuses on the effect of the GxE 
interaction (where E represents cell proportions) for explaining the variation in gene 
expression, and it only incorporates one cell type at each time. To properly compare 
Decon-eQTL with the Westra ​et al​ method, coined here ‘Westra method’, both methods were 
applied to the BIOS cohort, where we detected CT eQTLs for the six cell subpopulations. 
Replication of CT eQTLs from Westra method was done in the same way as described 
above for Decon-eQTL. We observed that the eGenes (i.e. genes with eQTLs) detected by 
the Westra method are significantly higher expressed for granulocytes (observed in purified 
neutrophils), CD4+ T cells and B cells, but not for CD14+ monocytes (Supplementary Fig. 
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 15A). Next, we found that the distribution of effect sizes in eQTLs from purified cells is 
significantly higher for the CT eQTLs detected using the Westra ​et al​ method when 
compared to the rest of the whole blood eQTLs (boxed-diagonal comparisons in 
Supplementary Fig. 15B), showing similar results as the ones from Decon-eQTL. However, 
their performance differentiates when comparing effect sizes of eQTLs of non-relevant cell 
subpopulations (off diagonal comparisons in Supplementary Fig. 16), where the Westra 
method shows less CT specificity, mainly across neutrophils and CD14+ monocytes, as 
observed by a significant difference (Wilcoxon test p-value = 4x10 ​-08​, Fig S15B), whereas 
from Decon-eQTL this comparison yields a non significant difference (Wilcoxon test p-value 
= 5.2x10 ​-02​). This difference in effect sizes by the Westra method in non-relevant cell 
subpopulations is also observed for eQTLs detected in CD14+ monocytes by the Westra 
method when compared to CD4+ T cell effect sizes. These results suggest that the results 
obtained with the Westra method are not as specific as the ones detected by Decon-eQTL. 
 
When comparing the allelic concordance rates between the direction of effects given by the 
interaction term from the Westra method and those found in eQTLs from purified cell 
subpopulations, we observed that the allelic concordance for granulocytes eQTLs, 99%, 
(evaluated in neutrophils) and for CD4+ T cells, 100% (Supplementary Fig.16) is comparable 
as to those observed for Decon-eQTL (Fig.4A). Conversely, the allelic concordance rate for 
the CD14+ monocytes is only 28%, much lower than the results from Decon-eQTL(96%). 
Finally, for granulocytes, CD4+ T cell eQTLs and monocytes, we have overlapped the the 
results from Westra method and Decon-eQTL with the eQTLs from purified cell types (Chen 
et al) (Supplementary Fig. 17). For all three cell types, we found that Decon-eQTL is able to 
detect a larger number of eQTLs, with a similar replication rate as the Westra method. 
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 The Zhernakova et al method ​11​ uses modules of co-expressed genes from whole blood 
RNA-seq data to ascertain the effect on context/CT dependent eQTLs.  We compared our 
Decon eQTL results with those from the Zhernakova method for neutrophils, CD4+ and 
CD8+ T-cells, CD14+ monocytes, and B-cells. The reported Z-scores for bulk whole blood 
eQTLs identified by Zhernakova ​et al​ were used to infer the allelic direction for each 
available CT. Again, we compared the direction of the eQTL effect with that of the purified 
neutrophils, CD4+ T-cell and CD14+ monocyte eQTLs​9​. Zhernakova et al. detected fewer 
CT eQTLs effects compared to Decon-eQTL(​Fig. 3A ​for Decon-eQTL, Supplementary Fig. 
18A). Although the eQTLs from the neutrophil module showed 100% concordance with the 
purified neutrophils, slightly outperforming Decon-eQTL (99% allelic concordance) 
(Supplementary Fig. 18B),  the concordance rate for the other two cell types (80% for CD14+ 
monocytes module and 95% for CD4+ module) are lower than those from Decon-eQTL (96% 
and 99% respectively). Overall, these results demonstrate that Decon-eQTL is able to detect 
more CT eQTLs that can be replicated in purifiec eQTL dataset that previously reported 
methods, specially in not so abundant cell types such as CD14+ monocytes. However, the 
detection of interaction effects between genotype and cell proportions to dissect bulk (in this 
case whole blood) expression data and define cell type eQTLs remains an area of 
opportunity that could still be explored by the increase number of samples present in 
functional genomic cohorts and the greater number of purified eQTL dataset that can be 
used for validation.  
Discussion 
We have developed a novel statistical framework, Decon2, which predicts the proportions of 
known cell subtypes using gene expression levels from bulk blood tissue (Decon-cell). 
Subsequently, these predicted cell proportions, together with genotype information and 
expression data, can be used to deconvolute a bulk eQTL effect into cell-type effects 
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 (Decon-eQTL). Using a set of samples with both whole blood RNA-seq data and cell 
frequencies of 73 cell subpopulations, we demonstrated that Decon-cell was able to predict 
34 independent cell subpopulations. The performance of Deocn-cell has been extensively 
validated by using multiple independent cohorts and compared with existing methods. The 
obtained Decon-cell models were applied to a cohort of 3,189 samples with whole blood 
RNA-seq available, resulting in predicted cell counts for these samples. By integrating bulk 
expression data, genotype and predicted cell counts of BIOS cohort,  Decon-eQTL was able 
to dissect whole blood eQTL effect into CT eQTLs without purifying immune cell 
subpopulations. Again the results of Decon-eQTL were validated by using several 
independent data types: 1) eQTLs from purified eQTL dataset, 2) chromatin QTLs purified 
eQTL dataset 3) gene expression from purified cell types. Compared with existing methods, 
Decon-eQTL consistently show superior performance. To sum up, the proposed framework 
is useful for analyze/re-analyzing both existing and new bulk bloodtissue datasets to detect 
cell-type eQTL effects, and can be applied and tested on other tissues once cell count 
proportions become available. This will improve our understanding of the functional role of 
SNPs associated to complex diseases, at the level of specific cell subtypes. 
  
The main advantage of our method for predicting cell proportions by Decon-cell  is that it 
does not rely on the gene expression measured in purified cell subtypes when defining 
signature gene sets. Moreover, our method does not require the definition of marker genes 
based on their differential expression compared to other cell subpopulations unlike 
previously reported methods​12​. The signature genes defined by Decon-cell are determined 
by a completely unsupervised approach using a regularized regression to select an optimal 
combination of genes to accurately predict a certain circulating cell proportion. Although the 
majority of these marker genes are differentially expressed across purified cell 
subpopulations, not all of them are. Nevertheless, these signature gene sets are still 
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 correlated to the cell proportions in whole blood. In summary, have shown that Decon-cell is 
able to accurately predict the proportions of circulating immune cell subpopulations in three 
independent cohorts and that within these cohorts it out-performs previously reported 
methods. 
  
Our Decon-eQTL method for detecting an CT eQTL effect with bulk blood tissue expression 
data is, to our knowledge, the first attempt to simultaneously model bulk blood gene gene 
expression profiles into its major components. In contrast to a previous method, where single 
cell type  (G x E) effects were evaluated one at a time ​10,31​, Decon-eQTL incorporates all the 
major cell proportions simultaneously to better dissect the overall genetic effect of gene 
expression signal into cell subpopulations. We have validated our Decon-eQTL results by 
using eQTLs from purified neutrophils, CD14+ monocytes and CD4+ T-cells. Furthermore, 
we have shown that the eQTLs detected by Decon-eQTL have significantly higher effect 
sizes, specifically in the relevant cell subpopulations and they show an allelic concordance of 
at least 96%. Moreover, we have also shown the biological relevance of the deconvoluted 
CT eQTLs by validating our results on cmQTLs where CT eQTLs have significantly higher 
effect sizes and its allelic concordance rates are significantly higher than those of whole 
blood eQTLs.  Finally, we have also demonstrated that Decon-eQTL can replicate CT eQTLs 
derived from single-cell RNA-seq data, showing a higher allelic concordance with sc-eQTLs 
compared to using only whole blood eQTL effects. 
  
There are limitations in our method: the CT eQTLs detected by Decon-eQTL tend to be 
exclusive eQTL for the specific CT suggesting that the CT with the strongest eQTL effect 
was selected by Decon-eQTL. This is  likely due to the partial collinearity present between 
CT proportions included in the model (as shown by their correlation structure in 
Supplementary Fig. 19A-B). Thus, the genetic effect of one cell type might be masked by 
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 another CT with correlated cell proportion. The highest correlation coefficient among cell 
types included in the model was 0.75 (between granulocytes and B cells). Therefore, a 
caveat to this is that by deconvoluting CT eQTLs for partially correlated cell proportions 
could lead to false negative results for the CTs with relatively weaker eQTL effects.  
 
The proposed framework of Decon2 is generic for predicting cell subpopulations in bulk 
tissues (Decon-cell) and re-distribute the overall eQTL effect into cell types (Decon-eQTL). 
Both methods have been implemented into freely available software. In both R package and 
webtool, the models for predicting cell subpopulation in whole blood constructed and 
validated in this work are provided for people interested in estimating immune cell 
subpopulations in whole blood in health people with western european ethnicity, as our 
models were built using a Dutch cohort (500FG).  
  
In summary, Decon2 is a computational method that can accurately assign CT effects in bulk 
blood eQTL datasets, which can be applied to any dataset for which genotypes and 
expression data is available to and potentially aid in our understanding of the molecular 
effects of genetic risk factors associated to complex diseases at cell type level. Our method 
makes it possible to create CT gene regulatory networks that could explain the different 
effects that each CT has on a complex disease in a cost-efficient way. Since Decon2 only 
requires  gene expression and genotype information to deconvolute eQTLs, it is possible to 
re-analyze the existing bulk blood RNA-seq data for which genotypes are also available; this 
is where we would use Decon-cell to predict cell proportions in whole blood and obtain CT 
information on many more eQTLs from an increase in sample size. The methods behind 
Decon2 can be potentially generalized to use transcriptional profiles derived from any other 
type of bulk tissue in addition to whole blood, such as biopsies from tumors or other solid 
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 tissues implicated in complex disease etiology. Our methods can hence aid in the detection 
of genetic effects on gene expression in rare cell subpopulations in bulk tissues.  
 
Methods 
RNA-seq data collection in 500FG cohort 
We selected a representative subset of 89 samples from the 500 participants of the 500FG 
cohort, which is part of the Human Functional Genomics Project (HFGP). Our subset was 
balanced for age and sex given the original distribution in the cohort, we performed RNA-seq 
in their whole blood samples. RNA was isolated from whole blood and subsequently globin 
transcripts were filtered by applying the Ambion GLOBINclear kit. The samples were then 
processed for sequencing using the library preparation kit Illumina TruSeq 2.0. Paired-end 
sequencing of 2×50-bp reads was performed on the Illumina HiSeq 2000 platform. The 
quality of the raw reads was checked using FastQC 
(​http://www​.bioinformatics.babraham.ac.uk/projects/fastqc/). Read alignment was performed 
with STAR 2.3.0 ​32,33​, using the human Ensembl GRCh37.75 as reference, whilst the aligned 
reads were sorted using SAMTools​34​. Lastly, gene level quantification of the reads was done 
using HTSeq ​35​. 
RNA-seq preparation and data processing in the BIOS cohort 
RNA was isolated from whole blood and subsequently globin transcripts were filtered by 
applying the Ambion GLOBINclear kit. Library preparation was performed using the Illumina 
TruSeq v2 library preparation kit. Next, Illumina HiSeq 2000 was used to performed 
paired-end sequencing of 2 x 50 bp reads while pooling 10 samples per lane and expecting 
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 > 15 million read pairs per sample. By using CASAVA read sets were generated, retaining 
only reads that passed Illumina Chastity Filter for further processing. 
Quality control of the reads was evaluated using FastQC 
(​http://www.bioinformatics.babraham.ac.uk/projects/fastqc/​). Adaptor sequences were 
trimmed out using cutadapt (v1.1) using default settings. Low quality ends of reads were 
removed using Sickle (v1.200) (​https://github.com/najoshi/sickle ​).  
Reads were then aligned using STAR 2.3.0e ​33​. All SNPs present in the Genome of the 
Netherlands (GoNL) with MAF ≥ 0.01 were masked from the reads to avoid reference 
mapping bias. Read pairs with at most eight mismatches and mapping to at most five 
positions, were used. Quantification of counts per genes was done using Ensembl v.71 
annotation (which corresponds to GENCODE v.16). 
Genotype data of t​he BIOS cohort 
Genotype information was independently generated by each of the cohorts, further details on 
data collection and and methods used for genotyping can be found in their papers 
(CODAM​36​, LLDeep ​16​, LLS​17​, RS​18​ and NTR​37​) 
Genotypes were harmonized to GoNL with Genotype Harmonizer​38​  and imputed using 
IMPUTE2 ​39​ using GoNL as reference panel. SNPs with an imputation score below 0.5, 
Hardy–Weinberg equilibrium P value smaller than 1×10 ​−4​, a call rate below 95% or a MAF 
smaller than 0.05 were filtered out. For further analysis only eSNPs from whole blood 
cis-eQTLs top effects were subsequently used in Decon-eQTL.  
 
Quantification of cell proportions in 500FG cohort 
The inclusion criteria and further description of the participants of the 500FG cohort can be 
found at​ ​http://www.humanfunctionalgenomics.org ​. A total of 73 manually annotated immune 
cell subpopulations were quantified using 10-color flow cytometry. To minimize biological 
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 variability, cells were processed immediately after blood sampling and typically analyzed 
within 2–3 hr. Cell populations were gated manually as previously described ​14​. 
cis-​eQTLs in the BIOS cohort 
For ​cis​-QTL mapping, we tested association between genes and SNPs located within 250 kb 
of a gene center. SNPs with MAF ≥ 0.01, call rate = 1 and Hardy–Weinberg equilibrium 
p-value ≥ 0.0001 were included. eQTLs were declared to be significant at FDR < 0.05. 
Pre-processing of RNA-seq and QTL mapping was performed using a custom eQTL pipeline 
which has been previously described ​11​. 
Prediction of cell proportions using gene expression levels from bulk tissue 
(Decon-cell)  
We proposed that the abundance of molecular markers such as gene expression could be 
used as proxies to predict cell proportions. This can be represented as: 
 β  Y  + eCkj =  ki ij  kj           (1) 
 
where expression data is Y​ij​ for genes ​i​ = 1, 2,…, G, and samples ​j ​ = 1, 2, …, ​N ​, and cell 
count data is C​kj​ for sample j in cell type ​k​ (k = 1, 2, …, K), whilst β ​ki​ represents the 
coefficients of gene ​i ​in determining cell counts of cell type ​k​ of a complex tissue and e ​kj​ is 
the error term. 
In order to select only the most informative genes for predicting cell counts, we implemented 
a feature selection scheme by applying an elastic net (EN) regularized regression ​25​. In the 
EN algorithm, the  are estimated by minimizing: Yβk   
β Y   subject to (1 )    α    ≤ s | | Ck −  k | |
2 − α  | | βk | |
2 +   | | βk | |1  (2) 
 
is a tuning parameter that limits the number of features that will be included in the finals  
predictor model. We estimate the best ​s​ per cell type by applying a 10-fold cross-validation 
approach, where the most optimal penalty parameter ( ) was obtained.α  
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 Normalization and correction of gene expression data for deconvolution of 
eQTL effects 
Total read counts from HTSeq were first normalized using the trimmed means of M (TMM) 
values​32​. TMM expression values were log2 transformed. For predicting cell proportions, we 
used scaled expression data in both the 500FG and BIOS cohorts. 
For the deconvolution of eQTLs, the expression was log2 transformed and corrected using a 
linear model for the effect of cohort, age, sex, GC content, RNA degradation rates, library 
size, and number of detected genes per sample. The corrected expression data is then 
exponentiated in order to maintain the original linear relationship across read counts (gene 
expression) and cell proportions. 
Deconvolution of eQTL effects (Decon-eQTL) 
Decon-eQTL models  the expression level in the bulk tissue by considering the genetic 
contribution of multiple  cell types present in the system. For identifying the CT eQTL effect, 
the interaction term between a particular cell type and genotype was tested for statistically 
significance contribution to the explained variance on the expression levels of particular 
gene, while accounting for the remaining cell proportions.  
If we consider a generic eQTL linear model for whole blood it can be described as: 
a β.g   y =  +  + e (3) 
where  is the measured gene expression, the modeled non-genetic dependenty  a  
expression,  the genotype coded as 0, 1 or 2,  the genotype-dependent expression,g .gβ  
and  the error, e.g. unknown environmental effects. Here all three terms are modeling thee  
effect of the mixture of different cell types present in blood.  
In an RNA-seq based gene expression quantification of a bulk tissue, one could express 
gene expression levels (  as the sum of counts  per  cell types:)y ψ)( K  
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For every cell type the expression level has can be written as a generic eQTL model 
(equation 3) weighted by the cell proportions.  ​ is a combination of the genetic and nonψk  
genetic contribution of the cell type to . ​ The non-genetic contribution per cell type is y . cβ   
where  is the cell count proportions, while the genetic contribution is . ​ For  cellc . gβk : ck k  
types the expression then is  
 Σ .( β . c ) Σ .(γ  g × c )   y = ∑
K
k=1
ψk =  k k k +  k k. k + e (5) 
Where  ​is the measured expression levels, is the total number of cell types,  is the celly k ck  
count proportions of cell type , is ​the genotype . And e is the error term. Since we arek g  
assuming a linear relationship between total gene expression and the levels of expression 
generated by each of the cell types composing a bulk tissue, the cell proportions are scaled 
to sum to 100%, such that the sum of the effect of the cell types equals the effect in whole 
blood. Here we ​assume that the true sum of the cell counts should be very close to 100% of 
the total PBMCs count, which is why we include the 6 cell types that together form the top 
hierarchy given the gating strategy used to quantify the cell subpopulations​14​. The genotype 
main effect is not include in the model as the sum of the genotype effect per cell type should 
approximate the main effect. 
Because the contribution of each of the cell types to expression level  can not be negative,y  
we constrain the terms of the model to be positive by using Non-Negative Least Squares​40,41 
to fit the parameters to the measured expression levels. However, if the allele that has a 
negative effect on gene expression is coded as 2, the best fit would have a negative 
interaction term, which would be set to 0. To address this we want the allele that causes a 
positive effect on gene expression to always be coded as 2. However, the effect of an allele 
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 has can be different per cell type, therefore the coding of the SNP should also be different 
per cell type. Therefore, we run the model multiple times, each time swapping the genotype 
encoding for one of the interaction terms. The encoding that gives the lowest R-squared is 
then chosen as the optimal genotype encoding. For the encoding we limit the amount of 
genotypes that have an opposite genotypic encoding to maximum of one interaction term, as 
we have observed that there no significant difference compared to using all possible 
configurations and this limits the amount of models that have to be run from k​2 ​to (2*k)+2. 
To test if there is a CT interaction effect we run the linear model of equation 5. and, for each 
CT, run the same model with the cell proportion:genotype interaction term removed. E.g. 
when testing two cell types the full model is  
β . c . c . g × c . g × c   y =  1 1 + β2 2 + γ1 1 + γ2 2 + e (6) 
and the two models with the interaction terms removed are  
β . c . c . g × c   y =  1 1 + β2 2 + γ1 1 + e (​7) 
β . c . c . g × c   y =  1 1 + β2 2 + γ2 2 + e  
For both the full model and the CT models we calculated the sum of squares using the 
different genotype configurations detailed above. For both the full and the CT models we 
then selected the genotype configuration with lowest sum of squares. Then, for each CT, we 
test if full model can significantly explain more variance than the CT model using an ANOVA.  
We have then applied our strategy to 16,362 significant whole blood cis-eQTLs top effects 
that were detected using the BIOS cohort. We then correct the p-values for multiple testing 
using FDR by each of the cell types, ​e.i​. Granulocyte eQTL p-values were corrected for 
16,362 tests, in the same way CD4+ T cells eQTL p-values were corrected for the exact 
same number of tests. 
 
25 
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/548669doi: bioRxiv preprint 
  
Contributions 
 C.W., L.F. and YL initialized the study. Y.L. and L.F. directed and supervised the project. 
Y.L. developed the statistical framework, together with L.F.. R.A-G,, N.K., L.F., and Y.L., 
performed data analysis and interpretation. J.D.T. was involved in the initial analysis. N.K. 
and R.A-G. made the software and webtool. A.C, U.V., M. Z, X.C., O.B.B., Z.B., I.R.P., P.D., 
C.J.X., M.S., I.J., S.W., I.J., S.S., V.K., H.J.P.M.K., L.A.B.J., M.G.N. and C.W. contributed to 
data collection, data analysis and interpretation. R.A-G, N.K., L.F., and Y.L. draft and revised 
the manuscript. All authors have read and approved the manuscript. 
 
Acknowledgements 
We thank K Mc Intyre and J Senior for editing the final text. We thank T. Spenkelink for the DeconCell 
web tool design. L.F. is supported by grants from the Dutch Research Council (ZonMW-VIDI 
917.164.455 to M.S. and ZonMW-VIDI 917.14.374 to L.F.), and by an ERC Starting Grant, grant 
agreement 637640 (ImmRisk). Y.L. was supported by an ZonMW-OffRoad grant (91215206). The 
HFGP is supported by a European Research Council (ERC) Consolidator grant (ERC 310372). This 
study was further supported by an IN-CONTROL CVON grant (CVON2012-03) and a Netherlands 
Organization for Scientific Research (NWO) Spinoza prize (NWO SPI 94-212) to M.G.N.; an ERC 
advanced grant (FP/2007-2013/ERC grant 2012-322698) and an NWO Spinoza prize (NWO SPI 
92-266) to C.W.; a European Union Seventh Framework Programme grant (EU FP7) TANDEM 
project (HEALTH-F3-2012-305279) to C.W. and V.K.; . RJX was supported by National Institutes of 
Health (NIH) grants - DK43351, AT009708, AI137325. A CONACYT-I2T2 scholarship (382117) to 
R.A-G. The Biobank-Based Integrative Omics Studies (BIOS) Consortium is funded by BBMRI-NL, a 
research infrastructure financed by the Dutch government (NWO 184.021.007). We thank the UMCG 
Genomics Coordination center, the UG Center for Information Technology and their sponsors 
BBMRI-NL & TarGet for storage and compute infrastructure. 
26 
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/548669doi: bioRxiv preprint 
 References 
1. Hindorff, L. A. ​et al. ​ Potential etiologic and functional implications of genome-wide 
association loci for human diseases and traits. ​Proc. Natl. Acad. Sci. U. S. A.​ ​106​, 
9362–9367 (2009). 
2. Ionita-Laza, I., McCallum, K., Xu, B. & Buxbaum, J. D. A spectral approach integrating 
functional genomic annotations for coding and noncoding variants. ​Nat. Genet.​ ​48​, 
214–220 (2016). 
3. Javierre, B. M. ​et al. ​ Lineage-Specific Genome Architecture Links Enhancers and 
Non-coding Disease Variants to Target Gene Promoters. ​Cell​ ​167​, 1369–1384.e19 
(2016). 
4. Westra, H.-J. ​et al. ​ Systematic identification of trans eQTLs as putative drivers of known 
disease associations. ​Nat. Genet.​ ​45​, 1238–1243 (2013). 
5. Joehanes, R. ​et al.​ Integrated genome-wide analysis of expression quantitative trait loci 
aids interpretation of genomic association studies. ​Genome Biol.​ ​18​, 16 (2017). 
6. Raj, T. ​et al. ​ Polarization of the effects of autoimmune and neurodegenerative risk 
alleles in leukocytes. ​Science​ ​344​, 519–523 (2014). 
7. Peters, J. E. ​et al. ​ Insight into Genotype-Phenotype Associations through eQTL 
Mapping in Multiple Cell Types in Health and Immune-Mediated Disease. ​PLoS Genet. 
12​, e1005908 (2016). 
8. Naranbhai, V. ​et al.​ Genomic modulators of gene expression in human neutrophils. ​Nat. 
Commun.​ ​6 ​, 7545 (2015). 
9. Chen, L. ​et al.​ Genetic Drivers of Epigenetic and Transcriptional Variation in Human 
Immune Cells. ​Cell​ ​167​, 1398–1414.e24 (2016). 
10. Westra, H.-J. ​et al. ​ Cell Specific eQTL Analysis without Sorting Cells. ​PLoS Genet.​ ​11​, 
e1005223 (2015). 
27 
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/548669doi: bioRxiv preprint 
 11. Zhernakova, D. V. ​et al.​ Identification of context-dependent expression quantitative trait 
loci in whole blood. ​Nat. Genet.​ ​49​, 139–145 (2017). 
12. Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity 
landscape. ​Genome Biol.​ ​18​, 220 (2017). 
13. Netea, M. G. ​et al. ​ Understanding human immune function using the resources from the 
Human Functional Genomics Project. ​Nat. Med.​ ​22​, 831–833 (2016). 
14. Aguirre-Gamboa, R. ​et al.​ Differential Effects of Environmental and Genetic Factors on 
T and B Cell Immune Traits. ​Cell Rep.​ ​17​, 2474–2487 (2016). 
15. Bakker, O. B. ​et al. ​ Integration of multi-omics data and deep phenotyping enables 
prediction of cytokine responses. ​Nat. Immunol.​ ​19​, 776–786 (2018). 
16. Tigchelaar, E. F. ​et al.​ Cohort profile: LifeLines DEEP, a prospective, general population 
cohort study in the northern Netherlands: study design and baseline characteristics. 
BMJ Open​ ​5 ​, e006772 (2015). 
17. Deelen, J. ​et al.​ Genome-wide association meta-analysis of human longevity identifies a 
novel locus conferring survival beyond 90 years of age. ​Hum. Mol. Genet.​ ​23​, 
4420–4432 (2014). 
18. Hofman, A. ​et al.​ The Rotterdam Study: 2014 objectives and design update. ​Eur. J. 
Epidemiol.​ ​28​, 889–926 (2013). 
19. van Greevenbroek, M. M. J. ​et al.​ The cross-sectional association between insulin 
resistance and circulating complement C3 is partly explained by plasma alanine 
aminotransferase, independent of central obesity and general inflammation (the 
CODAM study). ​Eur. J. Clin. Invest. ​ ​41​, 372–379 (2011). 
20. Schoenmaker, M. ​et al.​ Evidence of genetic enrichment for exceptional survival using a 
family approach: the Leiden Longevity Study. ​Eur. J. Hum. Genet.​ ​14​, 79–84 (2006). 
21. Willemsen, G. ​et al.​ The Netherlands Twin Register biobank: a resource for genetic 
epidemiological studies. ​Twin Res. Hum. Genet.​ ​13​, 231–245 (2010). 
28 
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/548669doi: bioRxiv preprint 
 22. Bonder, M. J. ​et al. ​ Disease variants alter transcription factor levels and methylation of 
their binding sites. ​Nat. Genet.​ ​49​, 131–138 (2017). 
23. Adams, D. ​et al.​ BLUEPRINT to decode the epigenetic signature written in blood. ​Nat. 
Biotechnol.​ ​30​, 224–226 (2012). 
24. van der Wijst, M. G. P. ​et al. ​ Single-cell RNA sequencing identifies celltype-specific 
cis-eQTLs and co-expression QTLs. ​Nat. Genet.​ ​50​, 493–497 (2018). 
25. Friedman, J., Hastie, T. & Tibshirani, R. Regularization Paths for Generalized Linear 
Models via Coordinate Descent. ​J. Stat. Softw.​ ​33​, 1–22 (2010). 
26. Newman, A. M. ​et al.​ Robust enumeration of cell subsets from tissue expression 
profiles. ​Nat. Methods​ ​12​, 453–457 (2015). 
27. Gruden, K. ​et al.​ A ‘crossomics’ study analysing variability of different components in 
peripheral blood of healthy caucasoid individuals. ​PLoS One​ ​7 ​, e28761 (2012). 
28. Davenport, E. E. ​et al.​ Discovering in vivo cytokine eQTL interactions from a lupus 
clinical trial. (2017). doi:​10.1101/118703 
29. Wilson, D. R., Sun, W. & Ibrahim, J. G. Mapping Tumor-Specific Expression QTLs In 
Impure Tumor Samples. (2017). doi:​10.1101/136614 
30. Geeleher, P. ​et al.​ Cancer expression quantitative trait loci (eQTLs) can be determined 
from heterogeneous tumor gene expression data by modeling variation in tumor purity. 
Genome Biol.​ ​19​, 130 (2018). 
31. Glastonbury, C. A., Alves, A. C., Moustafa, J. E.-S. & Small, K. S. Cell-type 
heterogeneity in adipose tissue is associated with complex traits and reveals 
disease-relevant cell-specific eQTLs. (2018). doi:​10.1101/283929 
32. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for 
differential expression analysis of digital gene expression data. ​Bioinformatics​ ​26​, 
139–140 (2010). 
33. Dobin, A. ​et al.​ STAR: ultrafast universal RNA-seq aligner. ​Bioinformatics​ ​29​, 15–21 
29 
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/548669doi: bioRxiv preprint 
 (2013). 
34. Li, H. ​et al.​ The Sequence Alignment/Map format and SAMtools. ​Bioinformatics​ ​25​, 
2078–2079 (2009). 
35. Anders, S., Pyl, P. T. & Huber, W. HTSeq--a Python framework to work with 
high-throughput sequencing data. ​Bioinformatics​ ​31​, 166–169 (2015). 
36. van Dam, R. M., Boer, J. M., Feskens, E. J. & Seidell, J. C. Parental history of diabetes 
modifies the association between abdominal adiposity and hyperglycemia. ​Diabetes 
Care​ ​24​, 1454–1459 (2001). 
37. Willemsen, G. ​et al.​ The Netherlands Twin Register biobank: a resource for genetic 
epidemiological studies. ​Twin Res. Hum. Genet.​ ​13​, 231–245 (2010). 
38. Deelen, P. ​et al.​ Genotype harmonizer: automatic strand alignment and format 
conversion for genotype data integration. ​BMC Res. Notes​ ​7 ​, 901 (2014). 
39. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation 
method for the next generation of genome-wide association studies. ​PLoS Genet.​ ​5 ​, 
e1000529 (2009). 
40. Zhou, X., Song, Y., Wang, L. & Liu, Q. Preconditioned GAOR methods for solving 
weighted linear least squares problems. ​J. Comput. Appl. Math.​ ​224​, 242–249 (2009). 




.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/548669doi: bioRxiv preprint 
 Figure Legends 
Figure 1. Workflow of application of Decon2 to predict cell counts followed by 
deconvolution of  whole blood eQTLs. ​With whole blood expression and FACS data of 
500FG samples, Decon-cell predicts cell proportions with selected marker genes of 
circulating immune cell subpopulations. Validations of Decon-cell were carried out on three 
independent cohorts where measurements of neutrophils/granulocytes, lymphocytes and 
monocytes CD14+ were available, alongside to expression profiles of whole blood. 
Benchmarking of Decon-cell was performed against CIBERSORT​26​ and xCell ​12​. Decon-cell 
was applied to an independent cohort (BIOS) to predict cell counts using whole blood 
RNA-seq. Decon-eQTL subsequently  integrates genotype and tissue expression data 
together with predicted cell proportions for samples in BIOS to detect cell type eQTLs. We 
validated Decon-eQTL using multiple independent sources, including  expression profiles of 
purified cell subpopulations, eQTLs and chromatin mark QTLs (cmQTLs) from purified 
neutrophils, monocytes CD14+ and CD4+ T cells​9​, and single cell eQTLs results​24​. 
Benchmarking of Decon-eQTL was carried out for  comparison with previously reported 
methods which detected cell type eQTL effects using whole blood expression data,  i.e. 
Westra method ​10​ and Zhernakova, ​et al​ method ​11​). 
 
Figure 2. Prediction of cell proportions using whole blood transcriptome by 
Decon-cell.​ (A) Distribution of prediction performance (Spearman correlation coefficient) of 
the 34 predictable cell types in 100 iterations of prediction within the 500FG cohort. (B) 
Cross- cohort validation in an independent Lifelines-Deep cohort (n=627): the measured 
and predicted cell proportions for neutrophils (given by granulocytes in 500FG), lymphocytes 
and monocytes are compared. 
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 Figure 3. Deconvolution of whole blood eQTLs into cell-type eQTLs. ​  By integrating 
proportions of cell subpopulations (predicted by Decon-cell), gene expression and genotype 
information, Decon-eQTL detect cell-type eQTLs. (A) The number of deconvoluted eQTLs in 
each cell type by using whole blood RNA-seq data of 3,189 samples in BIOS cohort. (B) 
Distribution of Spearman correlation coefficients between expression levels of deconvoluted 
eQTL gene and cell counts for each cell subpopulation. The deconvoluted eQTL genes show 
positive and statistically higher correlation (Spearman) with its relevant cell type proportions 
than compared to the rest (T test p value < 0.05) in an independent cohort (500FG). 
 
Figure 4. Validation of deconvoluted cell-type eQTLs. ​ (A) Expression of eQTL genes in 
purified cell subpopulations from BLUEPRINT​23​ is significantly higher in its relevant cell 
subpopulation compared to other available cell subtypes (green for granulocyte eQTL genes 
showing expression for purified neutrophils; orange for monocytes; purple for CD4+ T cells; 
pink for B cells). (B) Differential expressed genes (Adjusted p-value ≤ 0.5) between  CD4+ T 
cells and NK cells are significantly enriched for CT eQTLs effects on CD4+ T cells (dots in 
purple, Fisher exact P = 1.8x10 ​17​) and NK Cells (dots in yellow, Fisher exact P = 2.3x10 ​18​) 
respectively. (C) Deconvoluted eQTLs (FDR ≤ 0.05) show significantly larger effect sizes in 
the purified cell eQTLs data ​9​ ​compared to the rest of the whole blood eQTLs for which we 
do not detect cell type effect, as shown for  deconvoluted granulocyte eQTLs in neutrophil 
derived eQTLs (green); monocytes (orange); CD4+ T cells (purple). 
 
Figure 5. Allelic concordance of deconvoluted cell-type eQTLs with eQTLs from 
purified cells. ​ Deconvoluted CT QTLs show high allelic concordance compared to eQTLs 
from purified cell subpopulations​9​. (A) for granulocyte eQTLs (orange), Decon-eQTL 
achieved an allelic concordance of 99% compared to eQTLs from purified neutrophils. 
Similarly, the allelic concordance were 96%and 99% for monocytes and CD4+ T cells, 
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 respectively. They are higher than those observed for whole blood eQTLs when comparing 
to eQTLs from purified subpopulations. as shown in panel (B). Deconvoluted eQTLs show 
an allelic concordance of 95% for significant eQTLs obtained from single cell RNA-seq data 
24​ on monocytes CD14+, B cells, CD4+ T cells, CD8+ T cells and NK cells (C). 
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 Supplementary Materials 
Supplementary figures:  
Supplementary Figure 1: Prediction performance of Decon-cell within 500FG ​: The 
Y-axis represents the 73 immune cell types quantified by FACS in the 500FG cohort. The 
bar plot on the left panel shows the mean Prediction Performance (Spearman correlation 
coefficient between predicted and measured cells across 100-fold cross validations). On the 
right panel, box plots represent the distribution of the Prediction Performance within 100 
iterations of the cross validations. A cutoff of mean Prediction Performance ≥0.5 was applied 
to define predictable cell types (green).  
  
Supplementary Figure 2. Signature genes selected for prediction of cell proportions 
by Decon-cell: (A)​ Total number of marker genes (genes selected in ≥ 80% of all models in 
the 100 iterations) per predictable cell type. Different colors indicate different subpopulations. 
(B)​ The number of genes significantly correlated with cell counts (Spearman correlation, 
adjusted P ≤ 0.05)  (y-axis) shows the total number of significantly correlated genes , while 
the x-axis shows the prediction performance (x-axis). ​(C)​ Distributions of the total number of 
“strongly” correlated genes (absolute Spearman correlation ≥ 0.3) between predictable and 
unpredictable cell subpopulations. 
  
Supplementary Figure 3. Comparison of prediction performance between  Decon-cell 
and other existing methods. ​ (A) Performance of Decon-cell: he measured (x axis) and 
predicted cell proportions (y-axis)  were compared for neutrophils (given by granulocytes in 
500FG), lymphocytes and monocytes CD14+ and granulocytes three independent cohorts 
(shown by row, from top to bottom: LLDeep (n= 627 ), LLS (n= 660) , RS (n= 773)). (B) 
34 
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/548669doi: bioRxiv preprint 
 Comparison of prediction performance for Decon-cell, CIBERSORT and xCell in three 
independent cohorts for a total of 4 major immune subpopulations. 
 
Supplementary Figure 4. Prediction performance of xCell and CIBERSORT in three 
independent Dutch populations ( ​LLDeep, n= 627; LLS, n= 660; RS, n= 773)​.​  (A) Scatter 
plots showing on the x-axis the measured cell proportions of circulating immune cells and 
the xCell enrichment score on the y-axis. (B) Scatter plots showing on the x-axis the 
measured cell proportions of circulating immune cells and the predicted cell proportions 
given by CIBERSORT) 
 
Supplementary Figure 5. Expression of marker genes selected by Decon-cell. 
Expression levels (scaled, log2(TPM+1) of signature genes in the data in three purified cell 
subpopulations: CD4+ T cells ​(A)​, neutrophils/granulocytes ​(B)​ and monocytes ​(C)​ in the 
data from  the BLUEPRINT. Cell subpopulations are indicated in different colors by columns. 
Correlation of each of the signature genes and the cell subpopulation percentage in 500FG 
cohort is shown on green bar at the left-hand side of heatmaps figure,i.e. darker green 
correspond to higher correlations. 
  
Supplementary Figure 6. ​ ​Many of the deconvoluted eQTL are cell type exclusive. ​ The 
colored bar plot on the left shows the total number of significantly deconvoluted eQTLs in 
whole blood eQTLs (as shown also in Figure 2A). The gray bar plot shows the total number 
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 Supplementary Figure 7. ​  ​Variation of gene expression across samples for 
deconvoluted cell-type eQTLs genes in whole blood ​. Granulocyte eQTL genes show 
significantly higher variance across the BIOS samples (F test p-value ≤ 0.05) compared to 
those from monocytes, CD4+ T cells, CD8+ T cells, B cells and NK cells. 
 
Supplementary Figure 8. ​ ​Validation of deconvoluted eQTLs using effect sizes of 
eQTLs from purified cells. ​ Deconvoluted eQTLs (FDR ≤ 0.05) from BIOS cohort show a 
significantly bigger effect size in purified cell eQTLs​9​ from their relevant cell subtype 
compared to other whole blood eQTLs (diagonal boxed comparisons). The off-diagonal 
comparisons show that these eQTL genes are specific to a cell  subpopulation because the 
differences in effect sizes are non-significant in all but one (CD4+ T cell eQTL genes in 
monocyte-derived eQTLs). 
 
Supplementary Figure 9. Validation of deconvoluted eQTLs using effect sizes of 
K27AC​ QTLs from purified cells. ​Deconvoluted eQTLs (FDR ≤ 0.05) show a significantly 
bigger effect size for K27AC QTLs which have peaks located in the promoter region of the 
the eGenes from their relevant cell subtype compared to the rest of the significant whole 
blood eQTLs (diagonal boxed comparisons). The off-diagonal comparisons show that these 
eQTL genes are specific to a cell subtype  because the differences in effect sizes are 
non-significant in all but the comparisons across Neutrophils and Monocytes (CD14+). 
 
 
Supplementary Figure 10. ​ ​Validation of deconvoluted eQTLs using effect sizes of 
K4ME1 ​ QTLs from purified cells. ​Deconvoluted eQTLs (FDR ≤ 0.05) show a significantly 
bigger effect size for K4ME1 QTLs (where the eGenes is the closest gene tagging the 
K4ME1 QTLs peak)from their relevant cell subtype compared to the rest of the significant 
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 whole blood eQTLs (diagonal boxed comparisons). The off-diagonal comparisons show that 
these eQTL genes are specific to a cell subtype because the differences in effect sizes are 
non-significant in all but the comparisons between neutrophils and monocytes (CD14+). 
 
 Supplementary Figure 11. ​ ​Validation of deconvoluted eQTLs using allelic 
concordance with eQTLs results from purified cells. ​Deconvoluted eQTLs (FDR ≤ 0.05) 
show a high allelic concordance in their respective purified cell eQTLs. Top row shows allelic 
concordance of deconvoluted granulocyte eQTLs (all in green) against neutrophils, 
monocytes and CD4+ T cells. Second row shows deconvoluted monocyte eQTLs against 
purified cell eQTLs in the same order as top row; bottom row shows the same comparisons 
as for deconvoluted CD4+ eQTLs. Allelic concordance of the off-diagonal (comparing 
deconvoluted eQLTs with non-relevant cell types) show a consistent decrease in allelic 
concordance. 
 
Supplementary Figure 12. ​ ​Validation of deconvoluted eQTLs using allelic 
concordance with K27AC  results from purified cells. ​Deconvoluted eQTLs (FDR ≤ 0.05) 
show a high allelic concordance in their respective purified cell  K27AC QTLs. Top row 
shows allelic concordance of deconvoluted granulocyte eQTLs (all in green) against 
neutrophils, monocytes and CD4+ T cells derived K27AC QTLs. Second row shows 
deconvoluted monocyte eQTLs (all in orange) against purified cell K27AC QTLs in the same 
order as top row; bottom row shows the same comparisons as for deconvoluted CD4+ 
eQTLs (all in purple). Allelic concordance of the off-diagonal (comparing deconvoluted 
eQLTs with non-relevant cell types) show a consistent decrease in allelic concordance when 
compared to the relevant cell type comparisons. 
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 Supplementary Figure 13. Allelic concordance between whole blood eQTLs and 
K27AC QTLs​ for purified neutrophils, CD14+ monocytes and CD4+ T cells. 
 
Supplementary Figure 14. ​ ​Comparison of whole blood eQTLs with eQTLs from single 
cell RNA-seq ​Whole blood eQTLs show 89% allelic concordance for significant eQTLs 
derived from single-cell RNA-seq data, comprising monocytes CD14+, B cells, CD4+ T cells, 
CD8+ T cells and NK cells. 
 
Supplementary Figure 15. ​ ​Validation of cell type eQTLs detected in the BIOS cohort 
using Westra ​et at​, method ​: (A) Expression of eGenes in purified cell subpopulations from 
BLUEPRINT  (green for granulocyte eQTL genes showing expression for purified 
neutrophils; orange for monocytes; purple for CD4+ T cells; pink for B cells). (B) CT eQTLs 
detected by the Westra method show a significantly larger effect size in purified cell eQTLs​11 
compared to the rest of the whole blood eQTLs. Boxed-diagonal show the comparisons with 
relevant cell types, were the effect differences are stronger. 
 
Supplementary Figure 16. ​ ​Allelic concordance rates of cell type eQTLs detected using 
the Westra ​et al ​method and eQTLs from purified cells ​. Top row shows allelic 
concordance of granulocyte CT eQTLs against neutrophils, monocytes and CD4+ T cells. 
Second row shows CT monocyte eQTLs against purified cell eQTLs in the same order as 
top row; bottom row shows the same comparisons for CT CD4+ eQTLs. 
 
Supplementary Figure 17. ​ ​Comparison of Decon-eQTL with Westra ​et al​ method. 
Overlap of CT eQTLS detected with Decon-eQTL, the Westra ​et al​ method and those found 
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 to be significant in purified cell subpopulations, for granulocyte QTLs (A), CD4+ T cells (B), 
and monocytes (C). 
 
Supplementary Figure 18. ​ ​Comparison of Decon-eQTL with other methods for 
detecting cell type eQTLs ​. Total number of eQTLs per cell proportion module obtained by 
Zhernakova et al. (Nat Gen, 2017) (A). Allelic concordance between overall z-score for 
eQTLs from neutrophil, monocytes and CD4+ T cell modules against the effect size of 
purified eQTLs from neutrophils, monocytes and CD4+ T cells. 
  
Supplementary Figure 19. ​ ​Distribution and correlation among circulating cell 
proportions. ​  (A) With 89 samples from 500FG, the scatter plots show the correlations 
between different cell subpopulations. Blue line indicates a fitted linear model. Diagonal plots 
depict the overall density distribution per cell type. Upper right triangle shows the Pearson 
correlation coefficient for each pairwise comparison. (B) shows correlations between 




Supplementary table 1:  ​Ensembl IDs and symbol names of the marker genes selected by 
Decon-cell for the 34 predictable circulating immune cell proportions. 
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